LAG3 and neoplasm: We assessed the accuracy of the radiolabeled single-domain antibodies to image LAG-3 expression levels in the tumor by comparing ex vivo γ-counts with the activity that can be measured on SPECT/CT scans using AMIDE software (Fig. 2C).